慢性阻塞性肺疾病中CT肺血管与MRI通气成像:TINCan队列研究中与FEV1恶化的关系
研究纳入90例戒烟者(41例无COPD,49例COPD),间隔31±7个月两次行CT肺血管测量和3He MRI通气成像及肺功能检查。基线时COPD组与无COPD组间RA950、VDP、总血容量和PV1均有显著差异;PV1与FEV1%pred、FEV1/FVC及log RA950呈弱相关,与VDP无显著相关;PV1变化与RA950变化弱相关。
要点
- CT肺血管测量指标PV1在戒烟者与COPD患者间存在显著差异,并与RA950相关。
- PV1与VDP无显著相关,提示CT肺血管改变与MRI通气缺陷可能反映不同病理环节。
- FEV1年下降加速者的RA950和PV1年变化与FEV1年下降减缓者显著不同。
核心结论
- CT肺血管测量在戒烟者和COPD参与者中显著不同,并与RA950相关,但与VDP恶化无关。
研究设计与样本
- TINCan队列研究,纳入90例戒烟者(41例无COPD,年龄71±10岁;49例COPD,年龄71±8岁),间隔31±7个月两次行CT和3He MRI及肺功能检查。
关键影像表现/征象
- CT测量包括相对低衰减区面积(RA950,衰减<-950 HU)、肺血管总血容量(TBV)和半径小于一个体素的血管百分比(PV1)。
- 3He MRI用于生成通气缺陷百分比(VDP)。
- 基线时戒烟者与COPD参与者间RA950、VDP、总血容量和PV1均有显著差异(分别为p=0.0001、p=0.0001、p=0.0001、p=0.01)。
- COPD参与者中有无肺气肿者间VDP有显著差异(p=0.0001)。
诊断标准与关键数值
- PV1与FEV1%pred呈弱但显著相关(p=0.02)。
- PV1与FEV1/FVC呈弱但显著相关(p=0.001)。
- PV1与log RA950呈弱但显著相关(p=0.0001)。
- PV1与VDP无显著相关(p=0.20)。
- PV1平均变化与RA950变化呈弱但显著相关(p=0.02)。
临床应用与阅片要点
- CT肺血管测量指标PV1与RA950相关,但与VDP无显著相关,阅片时需注意两者反映不同信息。
- FEV1年变化在亚组间无显著差异(-40±93 mL/年,p=0.87),但FEV1年下降加速者的RA950年变化(p=0.01)和PV1年变化(p=0.007)与FEV1年下降减缓者显著不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The relationships between computed tomography (CT) pulmonary vascularity and MRI ventilation is not well-understood in chronic obstructive pulmonary disease (COPD) patients. Our objective was to evaluate CT pulmonary vascular and MRI ventilation measurements in ex-smokers and to investigate their associations and how such measurements change over time.
MATERIALS AND METHODS: Ninety ex-smokers (n = 41 without COPD 71 ± 10 years and n = 49 COPD 71 ± 8 years) provided written informed-consent to an ethics-board approved protocol and underwent imaging and pulmonary-function-tests twice, 31 ± 7 months apart. 3He MRI was acquired to generate ventilation-defect-percent (VDP). CT measurements of the relative area-of-the-lung with attenuation <-950 Hounsfield units (RA950), pulmonary vascular total-blood-volume (TBV) and percent of vessels with radius < one voxel (PV1) were evaluated.
RESULTS: At baseline, there were significant differences in RA950 (p = 0.0001), VDP (p = 0.0001), total-blood-volume (p = 0.0001) and PV1 (p = 0.01) between ex-smokers and COPD participants as well as for VDP (p = 0.0001) in COPD participants with and without emphysema. The annual FEV1 change (-40 ± 93 mL/year) was not different among participant subgroups (p = 0.87), but the annual RA950 (p = 0.01) and PV1 (p = 0.007) changes were significantly different in participants with an accelerated annual FEV1 decline as compared to participants with a diminished annual FEV1 decline. There were significant but weak relationships for PV1 with FEV1%pred (p = 0.02), FEV1/FVC (p = 0.001), and log RA950 (p = 0.0001), but not VDP (p=0.20). The mean change in PV1 was also weakly but significantly related to the change in RA950 (p = 0.02).
CONCLUSION: CT pulmonary vascular measurements were significantly different in ex-smokers and participants with COPD and related to RA950 but not VDP worsening over 2.5 years.
引用
- Barker AL, Eddy RL, MacNeil JL, et al. CT Pulmonary Vessels and MRI Ventilation in Chronic Obstructive Pulmonary Disease: Relationship with worsening FEV1 in the TINCan cohort study. Acad Radiol. 2020. PMID: 32303446. doi:10.1016/j.acra.2020.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。